Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessing the role of polygenic background on the penetrance of monogenic forms in Parkinson’s disease

View ORCID ProfileEmadeldin Hassanin, View ORCID ProfilePatrick May, View ORCID ProfileRana Aldisi, View ORCID ProfilePeter Krawitz, View ORCID ProfileCarlo Maj, View ORCID ProfileDheeraj Reddy Bobbili
doi: https://doi.org/10.1101/2021.06.06.21253270
Emadeldin Hassanin
1Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emadeldin Hassanin
Patrick May
2Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Sur-Alzette, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick May
Rana Aldisi
1Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rana Aldisi
Peter Krawitz
1Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Krawitz
Carlo Maj
1Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlo Maj
Dheeraj Reddy Bobbili
2Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-Sur-Alzette, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dheeraj Reddy Bobbili
  • For correspondence: dheeraj.bobbili@uni.lu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Several rare and common variants are associated with Parkinson’s disease. However, there is still an incomplete penetrance in the carriers of rare variants associated with Parkinson’s disease. To address this issue, we investigated whether a PRS calculated from significant GWAS SNPs affects the penetrance of Parkinson’s disease among carriers of rare monogenic variants in known Parkinson’s disease genes and those with a family history.

Methods We calculated the PRS based on common variants and selected the carriers of rare monogenic variants by using the exome data from UK Biobank. Individuals were divided into three risk categories based on PRS: low (<10%), intermediate (10%-90%), and high (>90%) risk groups. We then compared how PRS affects Parkinson’s disease risk among carriers of rare monogenic variants and those with family-history.

Results We observed a two-fold higher odds ratio for a carrier of a monogenic variant that had a high PRS (OR 4.07,95% CI, 1.72-8.08) compared to carriers with a low PRS (OR 1.91, 95% CI, 0.31-6.05). In the same line, carriers with a first-degree family history and with >90% PRS have even a higher risk of developing PD (OR 23.53, 95%CI 5.39-71.54) compared to those with <90% PRS (OR 9.54, 95% CI 3.32-21.65).

Conclusions Our results show that PRS, carrier status, and family history contribute independently and additively to the Parkinson’s disease risk.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

D.R.B. is supported by the Industrial fellowship program (FNR14323864) of the Fonds National de Recherche (FNR) Luxembourg. The FNR supported P.M. as part of the National Centre of Excellence in Research on Parkinson's disease (NCER-PD, FNR11264123) and the DFG Research Units FOR2715 (INTER/DFG/17/11583046) and FOR2488 (INTER/DFG/19/14429377). C.M. and E.H. are supported by the BONFOR-program of the Medical Faculty, University of Bonn (O-147.0002). The authors acknowledge the use of de.NBI cloud and the support by the High Performance and Cloud Computing Group at the Zentrum fur Datenverarbeitung of the University of Tubingen and the Federal Ministry of Education and Research (BMBF) through grant no 031A535A.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

I confirm all relevant ethical guidelines have been followed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Genome-wide genotyping data, exome-sequencing data, and phenotypic data from the UK Biobank and Parkinson's Progression Markers Initiative (PPMI) are available upon successful project application.

https://www.ukbiobank.ac.uk/

https://www.ppmi-info.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessing the role of polygenic background on the penetrance of monogenic forms in Parkinson’s disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessing the role of polygenic background on the penetrance of monogenic forms in Parkinson’s disease
Emadeldin Hassanin, Patrick May, Rana Aldisi, Peter Krawitz, Carlo Maj, Dheeraj Reddy Bobbili
medRxiv 2021.06.06.21253270; doi: https://doi.org/10.1101/2021.06.06.21253270
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Assessing the role of polygenic background on the penetrance of monogenic forms in Parkinson’s disease
Emadeldin Hassanin, Patrick May, Rana Aldisi, Peter Krawitz, Carlo Maj, Dheeraj Reddy Bobbili
medRxiv 2021.06.06.21253270; doi: https://doi.org/10.1101/2021.06.06.21253270

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9773)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (604)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4663)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)